ANKRD26 and myelodysplastic syndrome: In affected individuals, bone marrow morphology can demonstrate dyskmegakaryopoeisis with hypolobulated micromegakaryocytes at baseline, presenting a diagnostic challenge for hematopathologists to appropriately distinguish individuals with germline ANKRD26 mutations versus dysmegakaryopoiesis related to development of MDS [15].